<?xml version="1.0" encoding="UTF-8"?>
<p>NK cells have multiple antiviral functions. Upon activation by various stimuli, including IFN-I, they provide rapid killing of virus-infected cells before specific CD8 T cells expansion, and later modulate the adaptive immune response [
 <xref rid="B56-vaccines-08-00224" ref-type="bibr">56</xref>]. While NK cells are important in immune defense against DNA-virus, like Epstein Barr Virus or Cytomegalovirus, their relevance is less defined against RNA viruses, and there is no clear data about their role in coronaviruses immune response. NK cell levels in blood from severe SARS-CoV or SARS-CoV-2 patients were lower than normal, but this may not necessarily reflect a shortage of NK in lungs [
 <xref rid="B57-vaccines-08-00224" ref-type="bibr">57</xref>,
 <xref rid="B58-vaccines-08-00224" ref-type="bibr">58</xref>]. Of note, a trial with third party NK cells to treat Covid-19 is ongoing in China.
</p>
